Discover why Ventas, Inc. is gaining investor attention with strong momentum and bullish signals. Click for this look at VTR ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Jameson Kyle Boley, 40, is charged with unlawful manufacturing of a destructive device or bacteriological or biological ...

NZDJPYbreaks trend line support after long consolidation.As long as resistance at 91.50 persists, the intraday trend is ...

Gold holds above $4,360 after a 4% intraday drop, its sharpest since October. Price remains above rising long-term averages, ...

EMA validates Type II Variation marketing authorization application of Datroway as first-line treatment for patients with metastatic TNBC who are not candidates for immunotherapy ...

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® ...

Theriva Biologics ( ($TOVX) ) just unveiled an update. On December 29, 2025, Theriva Biologics reported that it received positive Scientific ...

The XRP price has dropped 2% in the past 24 hours as renowned analyst Ali Martinez warns the crypto could fall below $1.

Investing.com -- Theriva Biologics Inc (NYSE American:TOVX) stock surged 25.4% in Monday premarket trading after the company announced receiving positive scientific advice from the European Medicines ...

– Overall survival update for Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients planned in coming weeks – NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Immuneering ...

ETF AUM is climbing and DeFi TVL is rising—but charts warn the trend is weakening, with historical patterns pointing to a possible 50% drop if support fails.